Invention Grant
- Patent Title: CCL5 inhibitors
-
Application No.: US16724235Application Date: 2019-12-21
-
Publication No.: US10940132B2Publication Date: 2021-03-09
- Inventor: Bruce Kovacs
- Applicant: AFECTA PHARMACEUTICALS, INC.
- Applicant Address: US CA Irvine
- Assignee: AFECTA PHARMACEUTICALS, INC.
- Current Assignee: AFECTA PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Irvine
- Agency: Gorman IP Law, APC
- Main IPC: A61K31/216
- IPC: A61K31/216 ; A61P17/02 ; A61K45/00
Abstract:
Compounds, pharmaceutically acceptable salts, esters, prodrugs, and pharmaceutical compositions thereof are disclosed that are useful for inhibition of the biological activity of CCL5 on mammalian cells, as well as methods of treatment for diseases involving the increased biological activity of CCL5.
Information query
